Skip to main content
Wisconsin Registry for Alzheimer's Prevention
Frequently Asked Questions
Amyloid Disclosure Study
WRAP on NOVA
WRAP 20th Anniversary
Wisconsin Alzheimer’s Institute
School of Medicine and Public Health
Longer duration of hormonal contraceptive use predicts better cognitive outcomes later in life.
The effects of ramipril in individuals at risk for Alzheimer’s disease: results of a pilot clinical trial.
Advancing Alzheimer’s disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit.
CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer’s disease.
Machine learning amplifies the effect of parental family history of Alzheimer’s disease on list learning strategy.
Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.
Medial prefrontal functional connectivity–relation to memory self-appraisal accuracy in older adults with and without memory disorders.
Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer’s disease: a pilot study.